199 related articles for article (PubMed ID: 23676509)
1. Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor.
Enck RE; Abushahin F; Bossaer JB
J Oncol Pharm Pract; 2014 Apr; 20(2):137-40. PubMed ID: 23676509
[TBL] [Abstract][Full Text] [Related]
2. [A case of rectal gastrointestinal stromal tumor in an elderly patient who was successfully treated with imatinib mesylate with no significant adverse events].
Gomi K; Mihara M; Abe M; Ikeda Y; Shimada K; Maruyama K; Kajikawa S; Shirota H
Gan To Kagaku Ryoho; 2014 Jan; 41(1):103-6. PubMed ID: 24423962
[TBL] [Abstract][Full Text] [Related]
3. Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.
Hamza I; Gaies E; Kastalli S; Daghfous R; El Aidli S
Therapie; 2014; 69(3):245-7. PubMed ID: 24934821
[TBL] [Abstract][Full Text] [Related]
4. Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report.
Rediti M; Pellegrini E; Molinara E; Cerullo C; Fonte C; Lunghi A; Iori A; Neri B
Anticancer Res; 2014 Feb; 34(2):905-7. PubMed ID: 24511030
[TBL] [Abstract][Full Text] [Related]
5. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment].
Toyokawa T; Teraoka H; Kitayama K; Nomura S; Kanehara I; Nishino H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287
[TBL] [Abstract][Full Text] [Related]
6. A multicenter long-term study of imatinib treatment for Japanese patients with unresectable or recurrent gastrointestinal stromal tumors.
Ogata K; Mochiki E; Ojima H; Haga N; Fukuchi M; Aihara R; Ando H; Uchida N; Toyomasu Y; Suzuki M; Kimura A; Kogure N; Yokobori T; Ohno T; Kuwano H
J Surg Oncol; 2014 Dec; 110(8):942-6. PubMed ID: 25164620
[TBL] [Abstract][Full Text] [Related]
7. Imatinib-induced bone edema: case report and review of literature.
dos Santos LV; Lima JP; Abdalla KC; Bragagnoli AC; Santos FA; dos Anjos Jácome A; Porto FE
J Natl Compr Canc Netw; 2013 Oct; 11(10):1187-91. PubMed ID: 24142819
[TBL] [Abstract][Full Text] [Related]
8. Imatinib-induced pathologic changes including bile duct dilatation in hepatic metastases of gastrointestinal stromal tumor: case report and review of literature.
Lee YS; Lee SH; Choi YJ; Jung ES
J Cancer Res Ther; 2014; 10(3):763-6. PubMed ID: 25313780
[TBL] [Abstract][Full Text] [Related]
9. Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.
Kim H; Chang HM; Ryu MH; Kim TW; Sohn HJ; Kim SE; Kang HJ; Park S; Lee JS; Kang YK
J Korean Med Sci; 2005 Jun; 20(3):512-5. PubMed ID: 15953881
[TBL] [Abstract][Full Text] [Related]
10. [A case of rectal gastrointestinal stromal tumor (GIST) locally resected after long-term chemotherapy with imatinib mesylate].
Tonooka T; Takiguchi N; Yamamoto H; Nabeya Y; Ikeda A; Kainuma O; Souda H; Cho A; Muto Y; Yanagibashi H; Takano E; Denda T; Nagata M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1849-51. PubMed ID: 25731351
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of imatinib for treatment of metastatic GIST.
Patel S
Cancer Chemother Pharmacol; 2013 Aug; 72(2):277-86. PubMed ID: 23503753
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
[TBL] [Abstract][Full Text] [Related]
13. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
Dagher R; Cohen M; Williams G; Rothmann M; Gobburu J; Robbie G; Rahman A; Chen G; Staten A; Griebel D; Pazdur R
Clin Cancer Res; 2002 Oct; 8(10):3034-8. PubMed ID: 12374669
[TBL] [Abstract][Full Text] [Related]
14. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
Shen L; Jin ML
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
[TBL] [Abstract][Full Text] [Related]
15. Early onset imatinib mesylate-induced hepatotoxicity in a patient with gastrointestinal stromal tumors.
Yachoui R
Am J Ther; 2014; 21(5):e148-50. PubMed ID: 23567788
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of primary unresectable and/or recurrent gastrointestinal stromal tumors of small intestine presenting hemoperitoneum caused by administration of imatinib mesylate].
Yokoyama A; Dairaku N; Kusano M; Koshita S; Shimada N; Yamagiwa T; Kojima Y; Ojima T; Ikeya S; Nakayama H; Sugai Y; Hiwatashi N; Asano S
Nihon Shokakibyo Gakkai Zasshi; 2008 Nov; 105(11):1619-26. PubMed ID: 18987447
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor].
Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Kanazawa A; Tsukamoto T; Ikehara T; Nishiguchi Y
Gan To Kagaku Ryoho; 2014 Jan; 41(1):55-8. PubMed ID: 24423952
[TBL] [Abstract][Full Text] [Related]
18. Hepatic metastasis with heterologous rhabdomyoblastic differentiation in a patient with gastrointestinal stromal tumor treated with imatinib.
Vij M; Patra S; Rela M
Indian J Pathol Microbiol; 2013; 56(3):291-3. PubMed ID: 24152514
[TBL] [Abstract][Full Text] [Related]
19. Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate.
Kagimoto Y; Mizuashi M; Kikuchi K; Aiba S
Int J Dermatol; 2014 Mar; 53(3):e161-2. PubMed ID: 23786260
[No Abstract] [Full Text] [Related]
20. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].
Sassa M; Kobayashi Y; Sugeno H; Iwadate M; Suzuki S; Endo Y; Nakamura I; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2013 Jul; 40(7):937-41. PubMed ID: 23863741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
